Literature DB >> 14640983

Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.

Sárka Pospísilová1, Václav Brázda, Katerina Kucharíková, M Gloria Luciani, Ted R Hupp, Petr Skládal, Emil Palecek, Borivoj Vojtesek.   

Abstract

p53 is one of the most important regulators of cell proliferation and differentiation and of programmed cell death, triggering growth arrest and/or apoptosis in response to different cellular stress signals. The sequence-specific DNA-binding function of p53 protein can be activated by several different stimuli that modulate the C-terminal domain of this protein. The predominant mechanism of activation of p53 sequence-specific DNA binding is phosphorylation at specific sites. For example, phosphorylation of p53 by PKC (protein kinase C) occurs in undamaged cells, resulting in masking of the epitope recognized by monoclonal antibody PAb421, and presumably promotes steady-state levels of p53 activity in cycling cells. In contrast, phosphorylation by cdk2 (cyclin-dependent kinase 2)/cyclin A and by the protein kinase CK2 are both enhanced in DNA-damaged cells. We determined whether one mechanism to account for this mutually exclusive phosphorylation may be that each phosphorylation event prevents modification by the other kinase. We used non-radioactive electrophoretic mobility shift assays to show that C-terminal phosphorylation of p53 protein by cdk2/cyclin A on Ser315 or by PKC on Ser378 can efficiently stimulate p53 binding to DNA in vitro, as well as binding of the monoclonal antibody Bp53-10, which recognizes residues 371-380 in the C-terminus of p53. Phosphorylation of p53 by CK2 on Ser392 induces its DNA-binding activity to a much lower extent than phosphorylation by cdk2/cyclin A or PKC. In addition, phosphorylation by CK2 strongly inhibits PKC-induced activation of p53 DNA binding, while the activation of p53 by cdk2/cyclin A is not affected by CK2. The presence of CK2-mediated phosphorylation promotes PKC binding to its docking site within the p53 oligomerization domain, but decreases phosphorylation by PKC, suggesting that competition between CK2 and PKC does not rely on the inhibition of PKC-p53 complex formation. These results indicate the crucial role of p53 C-terminal phosphorylation in the regulation of its DNA-binding activity, but also suggest that antagonistic relationships exist between different stress signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14640983      PMCID: PMC1224005          DOI: 10.1042/BJ20030662

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies.

Authors:  V Brázda; J Paleĉek; S Pospísilová; B Vojtêsek; E Paleĉek
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

2.  Substrate specificity determinants of the checkpoint protein kinase Chk1.

Authors:  J R Hutchins; M Hughes; P R Clarke
Journal:  FEBS Lett       Date:  2000-01-21       Impact factor: 4.124

Review 3.  The cellular response to p53: the decision between life and death.

Authors:  R V Sionov; Y Haupt
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

4.  Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus.

Authors:  P Shaw; J Freeman; R Bovey; R Iggo
Journal:  Oncogene       Date:  1996-02-15       Impact factor: 9.867

5.  The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.

Authors:  G Selivanova; V Iotsova; E Kiseleva; M Ström; G Bakalkin; R C Grafström; K G Wiman
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

Review 6.  Regulation of p53 in response to DNA damage.

Authors:  N D Lakin; S P Jackson
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

7.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

8.  Mutation of phosphoserine 389 affects p53 function in vivo.

Authors:  M Hao; A M Lowy; M Kapoor; A Deffie; G Liu; G Lozano
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

9.  Dawn, diacylglycerol, calcium, and protein kinase C--the retinal wrecking crew. A signal transduction cascade for rhabdom shedding in the Limulus eye.

Authors:  R N Jinks; R H White; S C Chamberlain
Journal:  J Photochem Photobiol B       Date:  1996-08       Impact factor: 6.252

10.  Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.

Authors:  C W Stephen; P Helminen; D P Lane
Journal:  J Mol Biol       Date:  1995-04-21       Impact factor: 5.469

View more
  8 in total

1.  Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.

Authors:  Petr Muller; Juliana M Chan; Oliver Simoncik; Miroslav Fojta; David P Lane; Ted Hupp; Borivoj Vojtesek
Journal:  Protein Sci       Date:  2017-12-08       Impact factor: 6.725

2.  Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo.

Authors:  Elizabeth A Slee; Barbara Benassi; Robert Goldin; Shan Zhong; Indrika Ratnayaka; Giovanni Blandino; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

3.  A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function.

Authors:  Jennifer A Fraser; Borivoj Vojtesek; Ted R Hupp
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

Review 4.  Targeting CK2-driven non-oncogene addiction in B-cell tumors.

Authors:  E Mandato; S Manni; F Zaffino; G Semenzato; F Piazza
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

5.  p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.

Authors:  Francisco M Vega; Ana Sevilla; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  Enzyme-Linked Electrochemical Detection of PCR-Amplified Nucleotide Sequences Using Disposable Screen-Printed Sensors. Applications in Gene Expression Monitoring.

Authors:  Petra Horaková-Brazdilova; Miloslava Fojtova; Karel Vytras; Miroslav Fojta
Journal:  Sensors (Basel)       Date:  2008-01-21       Impact factor: 3.576

7.  Small molecule targeting miR-34a for cancer therapy.

Authors:  Zhangang Xiao; Yangchao Chen
Journal:  Mol Cell Oncol       Date:  2015-02-24

8.  Characterization of p53 Family Homologs in Evolutionary Remote Branches of Holozoa.

Authors:  Martin Bartas; Václav Brázda; Jiří Červeň; Petr Pečinka
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.